3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
9
Gastrointestinal
6
Myeloid
5
Lymphoid
5
Genitourinary
5
CNS
5
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Ovarian Neoplasms
34
Uterine Cervical Neoplasms
24
Fallopian Tube Neoplasms
18
Endometrial Neoplasms
16
Neoplasm Metastasis
10
Lung Neoplasms
9
Pancreatic Neoplasms
8
Stomach Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Transitional Cell
7
Breast Neoplasms
7
Melanoma
6
Carcinoma, Renal Cell
6
Prostatic Neoplasms
5
Esophageal Neoplasms
5
Carcinosarcoma
5
Carcinoma, Hepatocellular
5
Vaginal Neoplasms
4
Triple Negative Breast Neoplasms
4
Thyroid Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Testicular Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Multiple Myeloma
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Vulvar Neoplasms
2
Interventions
Doxorubicin
3
Filgrastim
2
Cytoreduction Surgical Procedures
2
Cisplatin
2
thymoglobulin
1
sodium thiosulfate
1
saracatinib
1
perifosine
1
brostallicin
1
X-Rays
1
Trabectedin
1
Thiotepa
1
Temozolomide
1
Sunitinib
1
Stem Cell Transplantation
1
Specimen Handling
1
Rituximab
1
Radiotherapy
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Immunologic Techniques
1
Imatinib Mesylate
1
Ifosfamide
1
Hyperthermic Intraperitoneal Chemotherapy
1
Granulocyte Colony-Stimulating Factor
1
Clofarabine
1
Chromatography, High Pressure Liquid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Magnetic Resonance Spectroscopy
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled